Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Hypertension. 2013 Mar 11;61(5):964–971. doi: 10.1161/HYPERTENSIONAHA.111.00289

Figure 3.

Figure 3

Hazard ratios for the composite cardiovascular end point in untreated (left) and treated (right) conventional normotensive subjects without (DM−) and with (DM+) diabetes mellitus and with masked hypertension (M-HT; conventional blood pressure [CBP] <140/90 mm Hg and daytime ambulatory blood pressure [dABP] ≥135/85 mm Hg). The sustained normotensives (NT; CBP <140/90 mm Hg and dABP <135/85 mm Hg), stage 1 hypertensives (S1-HT; CBP 140-159/90-94 mm Hg), and stage 2 hypertensives (S2-HT; CBP ≥160/95 mm Hg) were used as reference groups. Horizontal lines denote the 95% confidence interval. All analyses were adjusted for cohort, sex, age, body mass index, smoking and drinking, history of cardiovascular disease, and total serum cholesterol. Numbers are the number of subjects (left column) and number of events (right column) in the reference groups. Significance of the hazard ratios: *0.05≤P<0.06; †P<0.05; ‡P<0.01; and §P<0.001.